-
1261
-
1262
Development and validation of a machine learning-based model to predict survival in patients with cirrhosis after transjugular intrahepatic portosystemic shuntResearch in context
Published 2025-01-01“…The RF model outperformed other scoring systems, such as the (Child-Turcotte-Pugh score) CTP, (model for end-stage liver disease) MELD, (sodium MELD) MELD-Na, (Freiburg index of post-TIPS survival) FIPS and (Albumin-Bilirubin) ALBI, showing the highest (area under the curve) AUC of 0.82 (95% CI: 0.72, 0.91) and 0.7 (95% CI: 0.60, 0.79) in predicting 1-year survival across the testing set and external validation cohort. …”
Get full text
Article -
1263
Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma
Published 2025-02-01Get full text
Article -
1264
Slow Metabolism–Driven Amplification of Hepatic PPARγ Agonism Mediates Benzbromarone‐Induced Obesity‐Specific Liver Injury
Published 2025-01-01“…Abstract Obesity and nonalcoholic fatty liver disease (NAFLD) are established risk factors for drug‐induced liver injury (DILI). …”
Get full text
Article -
1265
A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma
Published 2021-01-01“…Cytochrome P450 2E1 (CYP2E1) is a key target protein in the development of alcoholic and nonalcoholic fatty liver disease (FLD). The pathophysiological correlate is the massive production of reactive oxygen species. …”
Get full text
Article -
1266
Sex differences in murine MASH induced by a fructose-palmitate-cholesterol-enriched diet
Published 2025-02-01“…Background & Aims: Metabolic syndrome-associated steatotic liver disease (MASLD) and metabolic syndrome-associated steatohepatitis (MASH) have global prevalence rates exceeding 25% and 3-6%, respectively. …”
Get full text
Article -
1267
Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndrome
Published 2025-03-01“…Methods: Circulating PlGF levels were measured in 64 controls and 137 patients with liver disease, with or without HPS. Two rat models, common bile duct ligation (CBDL) and long-term partial portal vein ligation (PPVL), were used. …”
Get full text
Article -
1268
-
1269
-
1270
-
1271
Achieving chronic hepatitis B functional cure: Factors and potential mechanisms
Published 2025-01-01Get full text
Article -
1272
Investigating the Activity Status of Inflammatory Bowel Disease and its Related Factors: A Study Protocol
Published 2025-01-01Get full text
Article -
1273
Isoniazid and Rifampicin Produce Hepatic Fibrosis through an Oxidative Stress-Dependent Mechanism
Published 2020-01-01Get full text
Article -
1274
Dysfunction of ATP7B Splicing Variant Caused by Enhanced Interaction With COMMD1 in Wilson DiseaseSummary
Published 2025-01-01Get full text
Article -
1275
-
1276
-
1277
-
1278
The Association of Depression and Anxiety Disorders With Gastrointestinal Symptoms Among Nurses
Published 2025-01-01Get full text
Article -
1279
-
1280